NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis 
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
Amazon in Advanced Talks to Acquire Globalstar in Starlink Rivalry Move 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
SK Hynix Shares Hit Record High Amid AI Memory Demand Surge 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
MENLO PARK, Calif., April 05, 2016 -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the 15th Annual Needham Healthcare Conference in New York at 8:40 a.m. Eastern Time on Tuesday, April 12, 2016.
A live webcast of the presentation will be available through the Investor Relations pages of Geron’s website and at http://wsw.com/webcast/needham76/gern. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT: Anna Krassowska, Ph.D. Investor and Media Relations 650-473-7765 [email protected] [email protected]
